Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Moderna Inc. says new data show its seasonal flu vaccine is 26.6% more effective than a licensed standard-dose seasonal flu ...

Moderna flu vaccine delivers mixed results in trial, shares fall. By Patrick Wingrove and Michael Erman. February 17, 2023 1:02 AM UTC Updated February 17, 2023 A sign marks the ...

What to know about Moderna’s combined covid-flu vaccine on the horizon. Moderna’s combined coronavirus and influenza mRNA shot generated higher immune responses in older adults than the ...

If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times if a new virus strain emerges. HHS pointed to the swine flu pandemic in 2009.